Inhibition of orthotopic osteosarcoma growth and metastasis by multitargeted antitumor activities of pigment epithelium-derived factor

Clinical and Experimental Metastasis

Volumn 24, Issue 2, 2007, Pages 93-106

  Ek, Eugene T H ^a   Dass, Crispin R ^a   Contreras, Karla G ^a   Choong, Peter F M ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

Angiogenesis; Antitumor; Metastasis; Osteosarcoma; PEDF; Targeted therapy

Indexed keywords

ALKALINE PHOSPHATASE; COLLAGEN TYPE 1; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; OSTEOCALCIN; PIGMENT EPITHELIUM DERIVED FACTOR; PROCOLLAGEN; PROCOLLAGEN ALPHA1; RECOMBINANT PIGMENT EPITHELIUM DERIVED FACTOR; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL ADHESION; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; EXPERIMENTAL MODEL; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LUNG METASTASIS; METASTASIS INHIBITION; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOSARCOMA; RAT; TUMOR VASCULARIZATION; UPREGULATION; WOUND HEALING;

ANIMALS; APOPTOSIS; BASE SEQUENCE; BLOTTING, WESTERN; CELL DIVISION; CELL LINE, TUMOR; DNA PRIMERS; EYE PROTEINS; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NERVE GROWTH FACTORS; OSTEOSARCOMA; RATS; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SERPINS;

EID: 34247621392     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10585-007-9062-1     Document Type: Article

References (46)

1. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57-70
2. Ferrari S, Smeland S, Mercuri M et al (2005) Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma groups. J Clin Oncol 23:8845-8852
3. Petrilli AS, de Camargo B, Filho VO et al (2006) Results of the Brazilian Osteosarcoma treatment group studies III and IV: prognostic factors and impact on survival. J Clin Oncol 24:1161-1168
4. Ek ET, Choong PF (2006) The role of high-dose therapy and autologous stem cell transplantation for pediatric bone and soft tissue sarcomas. Expert Rev Anticancer Ther 6:225-237
5. Quan GM, Ojaimi J, Nadesapillai AP et al (2002) Resistance of epiphyseal cartilage to invasion by osteosarcoma is likely to be due to expression of antiangiogenic factors. Pathobiology 70:361-367
6. Dawson DW, Volpert OV, Gillis P et al (1999) Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 285:245-248
7. Volpert OV, Zaichuk T, Zhou W et al (2002) Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium-derived factor. Nat Med 8:349-357
8. Cai J, Jiang WG, Grant MB et al (2006) Pigment epithelium-derived factor inhibits angiogenesis via regulated intracellular proteolysis of vascular endothelial growth factor receptor 1. J Biol Chem 281:3604-3613
9. Pignolo RJ, Francis MK, Rotenberg MO et al (2003) Putative role for EPC-1/PEDF in the G0 growth arrest of human diploid fibroblasts. J Cell Physiol 195:12-20
10. Abe R, Shimizu T, Yamagishi S et al (2004) Overexpression of pigment epithelium-derived factor decreases angiogenesis and inhibits the growth of human malignant melanoma cells in vivo. Am J Pathol 164:1225-1232
11. Crawford SE, Stellmach V, Ranalli M et al (2001) Pigment epithelium-derived factor (PEDF) in neuroblastoma: a multifunctional mediator of Schwann cell antitumor activity. J Cell Sci 114:4421-4428
12. Filleur S, Volz K, Nelius T et al (2005) Two functional epitopes of pigment epithelial-derived factor block angiogenesis and induce differentiation in prostate cancer. Cancer Res 65:5144-5152
13. Ek ET, Dass CR, Choong PF (2006) Pigment epithelium-derived factor: a multimodal tumor inhibitor. Mol Cancer Ther 5:1641-1646
14. Hase R, Miyamoto M, Uehara H et al (2005) Pigment epithelium-derived factor gene therapy inhibits human pancreatic cancer in mice. Clin Cancer Res 11:8737-8744
15. Doll JA, Stellmach VM, Bouck NP et al (2003) Pigment epithelium-derived factor regulates the vasculature and mass of the prostate and pancreas. Nat Med 9:774-780
16. Cheung LW, Au SC, Cheung AN et al (2006) Pigment epithelium-derived factor is estrogen sensitive and inhibits the growth of human ovarian cancer and ovarian surface epithelial cells. Endocrinology 147:4179-4191
17. Fisher JL, Mackie PS, Howard ML et al (2001) The expression of the urokinase plasminogen activator system in metastatic murine osteosarcoma: an in vivo mouse model. Clin Cancer Res 7:1654-1660
18. Dass CR, Ek ET, Contreras KG et al (2006) A novel orthotopic murine model provides insights into cellular and molecular characteristics contributing to human osteosarcoma. Clin Exp Metastasis 23:367-380
19. Nadiminty N, Lou W, Lee SO et al (2006) Prostate-specific antigen modulates genes involved in bone remodeling and induces osteoblast differentiation of human osteosarcoma cell line SaOS-2. Clin Cancer Res 12:1420-1430
20. Fahmy RG, Dass CR, Sun LQ et al (2003) Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth. Nat Med 9:1026-1032
21. Ek ET, Dass CR, Choong PF (2006) PEDF: a potential molecular therapeutic target with multiple anti-cancer activities. Trends Mol Med 12:497-502
22. Meyer C, Notari L, Becerra SP (2002) Mapping the type I collagen-binding site on pigment epithelium-derived factor. Implications for its antiangiogenic activity. J Biol Chem 277:45400-45407
23. Quan GM, Ojaimi J, Li Y et al (2005) Localization of pigment epithelium-derived factor in growing mouse bone. Calcif Tissue Int 76:146-153
24. Choong PF, Martin TJ, Ng KW (1993) Effects of ascorbic acid, calcitriol, and retinoic acid on the differentiation of preosteoblasts. J Orthop Res 11:638-647
25. Takenaka K, Yamagishi S, Jinnouchi Y et al (2005) Pigment epithelium-derived factor (PEDF)-induced apoptosis and inhibition of vascular endothelial growth factor (VEGF) expression in MG63 human osteosarcoma cells. Life Sci 77:3231-3241
26. Streck CJ, Zhang Y, Zhou J et al (2005) Adeno-associated virus vector-mediated delivery of pigment epithelium-derived factor restricts neuroblastoma angiogenesis and growth. J Pediatr Surg 40:236-243
27. Garcia M, Fernandez-Garcia NI, Rivas V et al (2004) Inhibition of xenografted human melanoma growth and prevention of metastasis development by dual antiangiogenic/antitumor activities of pigment epithelium-derived factor. Cancer Res 64:5632-5642
28. Browne M, Stellmach V, Cornwell M et al (2006) Gene transfer of pigment epithelium-derived factor suppresses tumor growth and angiogenesis in a hepatoblastoma xenograft model. Pediatr Res 60:282-287
29. Viguet-Carrin S, Garnero P, Delmas PD (2006) The role of collagen in bone strength. Osteoporos Int 17:319-336
30. Takasaki S, Fujiwara S, Shinkai H et al (1995) Human type VI collagen: purification from human subcutaneous fat tissue and an immunohistochemical study of morphea and systemic sclerosis. J Dermatol 22:480-485
31. Hosomichi J, Yasui N, Koide T et al (2005) Involvement of the collagen I-binding motif in the anti-angiogenic activity of pigment epithelium-derived factor. Biochem Biophys Res Commun 335:756-761
32. Bilak MM, Corse AM, Bilak SR et al (1999) Pigment epithelium-derived factor (PEDF) protects motor neurons from chronic glutamate-mediated neurodegeneration. J Neuropathol Exp Neurol 58:719-728
33. Tombran-Tink J, Mazuruk K, Rodriguez IR et al (1996) Organization, evolutionary conservation, expression and unusual Alu density of the human gene for pigment epithelium-derived factor, a unique neurotrophic serpin. Mol Vis 2:11
34. Kuncl RW, Bilak MM, Bilak SR et al (2002) Pigment epithelium-derived factor is elevated in CSF of patients with amyotrophic lateral sclerosis. J Neurochem 81:178-184
35. Sawant S, Aparicio S, Tink AR et al (2004) Regulation of factors controlling angiogenesis in liver development: a role for PEDF in the formation and maintenance of normal vasculature. Biochem Biophys Res Commun 325:408-413
36. Uehara H, Miyamoto M, Kato K et al (2004) Expression of pigment epithelium-derived factor decreases liver metastasis and correlates with favorable prognosis for patients with ductal pancreatic adenocarcinoma. Cancer Res 64:3533-3537
37. Thomas DM, Johnson SA, Sims NA et al (2004) Terminal osteoblast differentiation, mediated by runx2 and p27KIP1, is disrupted in osteosarcoma. J Cell Biol 167:925-934
38. Tombran-Tink J, Chader GG, Johnson LV (1991) PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity. Exp Eye Res 53:411-414
39. Folkman J (1971) Tumor angiogenesis: therapeutic implications. N Engl J Med 285:1182-1186
40. Zaichuk TA, Shroff EH, Emmanuel R et al (2004) Nuclear factor of activated T cells balances angiogenesis activation and inhibition. J Exp Med 199:1513-1522
41. Zhang SX, Wang JJ, Gao G et al (2006) Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy. J Mol Endocrinol 37:1-12
42. Fidler IJ (2003) The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 3:453-458
43. Guan M, Pang CP, Yam HF et al (2004) Inhibition of glioma invasion by overexpression of pigment epithelium-derived factor. Cancer Gene Ther 11:325-332
44. Kido A, Tsutsumi M, Iki K et al (1999) Overexpression of matrix metalloproteinase (MMP)-9 correlates with metastatic potency of spontaneous and 4-hydroxyaminoquinoline 1-oxide (4-HAQO)-induced transplantable osteosarcomas in rats. Cancer Lett 137:209-216
45. Notari L, Miller A, Martinez A et al (2005) Pigment epithelium-derived factor is a substrate for matrix metalloproteinase type 2 and type 9: implications for downregulation in hypoxia. Invest Ophthalmol Vis Sci 46:2736-2747
46. Kozaki K, Miyaishi O, Koiwai O et al (1998) Isolation, purification, and characterization of a collagen-associated serpin, caspin, produced by murine colon adenocarcinoma cells. J Biol Chem 273:15125-15130